A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Baxter International Inc stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 1,225 shares of BAX stock, worth $39,971. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,225
Previous 1,225 -0.0%
Holding current value
$39,971
Previous $40,000 15.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 02, 2023

SELL
$37.58 - $52.57 $31,191 - $43,633
-830 Reduced 40.39%
1,225 $49,000
Q2 2022

Jul 26, 2022

SELL
$63.83 - $80.0 $66,383 - $83,200
-1,040 Reduced 33.6%
2,055 $132,000
Q1 2022

Apr 13, 2022

SELL
$76.85 - $89.45 $48,799 - $56,800
-635 Reduced 17.02%
3,095 $240,000
Q3 2021

Nov 12, 2021

SELL
$73.77 - $83.61 $78,417 - $88,877
-1,063 Reduced 22.18%
3,730 $300,000
Q2 2021

Aug 13, 2021

BUY
$80.5 - $88.01 $385,836 - $421,831
4,793 New
4,793 $386,000
Q1 2021

Apr 14, 2021

SELL
$76.38 - $86.03 $93,565 - $105,386
-1,225 Closed
0 $0
Q1 2020

Apr 15, 2020

SELL
$71.57 - $93.3 $3,578 - $4,665
-50 Reduced 3.92%
1,225 $99,000
Q4 2019

Jan 22, 2020

BUY
$76.7 - $88.45 $3,835 - $4,422
50 Added 4.08%
1,275 $107,000
Q2 2019

Aug 09, 2019

SELL
$73.44 - $82.41 $2,423 - $2,719
-33 Reduced 2.62%
1,225 $100,000
Q4 2018

Feb 13, 2019

SELL
$61.45 - $77.8 $14,870 - $18,827
-242 Reduced 16.13%
1,258 $83,000
Q1 2018

Apr 20, 2018

SELL
$62.56 - $72.26 $12,512 - $14,452
-200 Reduced 11.76%
1,500 $98,000
Q4 2017

Feb 08, 2018

SELL
$61.45 - $66.05 $6,820 - $7,331
-111 Reduced 6.13%
1,700 $110,000
Q3 2017

Oct 27, 2017

BUY
$59.5 - $64.61 $6,604 - $7,171
111 Added 6.53%
1,811 $114,000
Q2 2017

Aug 07, 2017

BUY
N/A
1,700
1,700 $0

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.4B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Loring Wolcott & Coolidge Fiduciary Advisors LLP Portfolio

Follow Loring Wolcott & Coolidge Fiduciary Advisors LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.